Literature DB >> 19636204

Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases.

E Fiore1, T Rago, M Scutari, C Ugolini, A Proietti, G Di Coscio, M A Provenzale, P Berti, L Grasso, S Mariotti, A Pinchera, P Vitti.   

Abstract

OBJECTIVE: We evaluated the association between thyroid autoimmunity and thyroid cancer in a retrospective series of unselected thyroid nodules submitted to fine-needle aspiration (FNA) cytology.
DESIGN: Anti-thyroid antibodies (TAb) were measured in patients with multinodular goiter (MNG) and single/isolated thyroid nodule (S/I) submitted to FNA. Thyroid lymphocytic infiltration (LI) on histology was studied in a subgroup of patients submitted to thyroidectomy; 13,021 patients were included: on cytology 622 had papillary thyroid cancer (c- PTC) and 12,399 benign thyroid nodular diseases (c-BTN). LI was evaluated in histological samples of 688 patients: 304 with PTC (h-PTC) and 384 with BTN (h-BTN).
RESULTS: TAb prevalence was not different in c-BTN and c-PTC (38.7% vs 35.6%). TAb were more frequent in c-BTN than c-PTC in females with MNG (40.1% vs 32.5%, p=0.02), and in c-PTC than in c-BTN in males with S/I (31.2% vs 20.4%, p=0.02) and, although not significantly, in females younger than 30 yr (35.1% vs 30.7%). The frequency and severity of LI was significantly higher in h-PTC than h-BTN, both in MNG (82.5% vs 45.0%, p<0.001) and S/I (85.6% vs 71.0%, p<0.001), but a higher number of patients with h-PTC had negative circulating TAb, despite the presence of moderate/severe LI.
CONCLUSIONS: TAb are weakly associated to PTC in males and young females, while they are more frequent in older females with BTN. The frequency and severity of LI is significantly higher in PTC than in BTN, but in cancer patients TAb are frequently negative, despite the evidence of histological thyroiditis. These data suggest that different kinds of immune response may be involved in PTC and BTN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636204     DOI: 10.1007/bf03345725

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

1.  The Sardinian Autoimmunity Study: 3. Studies on circulating antithyroid antibodies in Sardinian schoolchildren: relationship to goiter prevalence and thyroid function.

Authors:  A Loviselli; F Velluzzi; P Mossa; M A Cambosu; G Secci; F Atzeni; A Taberlet; A Balestrieri; E Martino; L Grasso; M Songini; G F Bottazzo; S Mariotti
Journal:  Thyroid       Date:  2001-09       Impact factor: 6.568

2.  THE RELATION OF THYROID CARCINOMA AND CHRONIC THYROIDITIS.

Authors:  R N HIRABAYASHI; S LINDSAY
Journal:  Surg Gynecol Obstet       Date:  1965-08

3.  Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland.

Authors:  M E DAILEY; S LINDSAY; R SKAHEN
Journal:  AMA Arch Surg       Date:  1955-02

4.  RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response.

Authors:  E Puxeddu; J A Knauf; M A Sartor; N Mitsutake; E P Smith; M Medvedovic; C R Tomlinson; S Moretti; J A Fagin
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

5.  Guidelines of the Papanicolaou Society of Cytopathology for the Examination of Fine-Needle Aspiration Specimens from Thyroid Nodules. The Papanicolaou Society of Cytopathology Task Force on Standards of Practice.

Authors: 
Journal:  Mod Pathol       Date:  1996-06       Impact factor: 7.842

6.  The sardinian autoimmunity study. 4. Thyroid and islet cell autoantibodies in sardinian pregnant women at delivery: a cross-sectional study.

Authors:  A Olivieri; G Pinna; A Lai; F Velluzzi; A Pilo; F Atzeni; G Guaita; R Cirillo; M Sorcini; S Carta; G F Bottazzo; S Mariotti
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

Review 7.  The immune response to papillary thyroid cancer.

Authors:  J R Baker
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

8.  ret/PTC-1 Activation in Hashimoto Thyroiditis.

Authors:  O. M. Sheils; J.J. O'eary; V. Uhlmann; K. Lättich; E. C. Sweeney
Journal:  Int J Surg Pathol       Date:  2000-07       Impact factor: 1.271

9.  Cancer risks in patients with chronic lymphocytic thyroiditis.

Authors:  L E Holm; H Blomgren; T Löwhagen
Journal:  N Engl J Med       Date:  1985-03-07       Impact factor: 91.245

10.  Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans.

Authors:  I Okayasu; M Fujiwara; Y Hara; Y Tanaka; N R Rose
Journal:  Cancer       Date:  1995-12-01       Impact factor: 6.860

View more
  18 in total

Review 1.  Complex thyroid nodules with nondiagnostic fine needle aspiration cytology: histopathologic outcomes and comparison of the cytologic variants (cystic vs. acellular).

Authors:  Luis García-Pascual; María-José Barahona; Montserrat Balsells; Carlos del Pozo; Jordi Anglada-Barceló; Jaume Casalots-Casado; Enrique Veloso; Juan Torres
Journal:  Endocrine       Date:  2010-11-06       Impact factor: 3.633

2.  Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.

Authors:  Xiaoyu Wu; Yu Lun; Han Jiang; Qingwei Gang; Shijie Xin; Zhiquan Duan; Jian Zhang
Journal:  Endocrine       Date:  2013-12-14       Impact factor: 3.633

3.  High prevalence of papillary thyroid carcinoma in nodular Hashimoto's thyroiditis at the first diagnosis and during the follow-up.

Authors:  F Boi; F Pani; P G Calò; M L Lai; S Mariotti
Journal:  J Endocrinol Invest       Date:  2017-09-05       Impact factor: 4.256

4.  Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules.

Authors:  F Boi; L Minerba; M L Lai; B Marziani; B Figus; F Spanu; A Borghero; S Mariotti
Journal:  J Endocrinol Invest       Date:  2012-08-29       Impact factor: 4.256

5.  Iodine, thyroid autoimmunity and cancer.

Authors:  Emilio Fiore; Francesco Latrofa; Paolo Vitti
Journal:  Eur Thyroid J       Date:  2015-03-03

6.  Thyroid autoimmunity: is really associated with papillary thyroid carcinoma?

Authors:  Alev Selek; Berrin Cetinarslan; Ilhan Tarkun; Zeynep Canturk; Berna Ustuner; Zeynep Akyay
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-08       Impact factor: 2.503

Review 7.  Papillary Thyroid Cancer and Hashimoto's Thyroiditis: An Association Less Understood.

Authors:  Akshay Anand; Kul Ranjan Singh; Jitendra Kumar Kushwaha; Nuzhat Hussain; Abhinav Arun Sonkar
Journal:  Indian J Surg Oncol       Date:  2014-07-04

8.  Hashimoto's thyroiditis pathology and risk for thyroid cancer.

Authors:  Rodis Paparodis; Shahnawaz Imam; Kristina Todorova-Koteva; Anca Staii; Juan Carlos Jaume
Journal:  Thyroid       Date:  2014-06-05       Impact factor: 6.568

9.  Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer.

Authors:  L L Cunha; R C Ferreira; M A Marcello; J Vassallo; L S Ward
Journal:  J Thyroid Res       Date:  2011-02-17

10.  Serum 8-OHdG and HIF-1α levels: do they affect the development of malignancy in patients with hypoactive thyroid nodules?

Authors:  Harman Ece; Erdogan Mehmet; Biray Avci Cigir; Dodurga Yavuz; Karadeniz Muammer; Gunduz Cumhur; Harman Mustafa; Cetinkalp Sevki; Saygılı Fusun; Ozgen Ahmet Gokhan
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.